These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11191881)

  • 1. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
    Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
    Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PON1 gene and detoxication.
    Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
    Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
    Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
    Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
    Furlong CE
    J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
    Costa LG; Richter RJ; Li WF; Cole T; Guizzetti M; Furlong CE
    Biomarkers; 2003; 8(1):1-12. PubMed ID: 12519632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
    Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
    Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
    Mutch E; Daly AK; Williams FM
    Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.
    Cole TB; Walter BJ; Shih DM; Tward AD; Lusis AJ; Timchalk C; Richter RJ; Costa LG; Furlong CE
    Pharmacogenet Genomics; 2005 Aug; 15(8):589-98. PubMed ID: 16007003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
    Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
    Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 1 (PON1) status and substrate hydrolysis.
    Richter RJ; Jarvik GP; Furlong CE
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):1-9. PubMed ID: 19071155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
    Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
    Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicologically relevant concentrations.
    Sogorb MA; García-Argüelles S; Carrera V; Vilanova E
    Chem Res Toxicol; 2008 Aug; 21(8):1524-9. PubMed ID: 18597495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.
    Jansen KL; Cole TB; Park SS; Furlong CE; Costa LG
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):142-53. PubMed ID: 19371602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
    Costa LG; Giordano G; Cole TB; Marsillach J; Furlong CE
    Toxicology; 2013 May; 307():115-22. PubMed ID: 22884923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.
    Coombes RH; Meek EC; Dail MB; Chambers HW; Chambers JE
    Toxicol Lett; 2014 Oct; 230(1):57-61. PubMed ID: 25093614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
    Li WF; Costa LG; Furlong CE
    J Toxicol Environ Health; 1993; 40(2-3):337-46. PubMed ID: 7693961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.
    Stevens RC; Suzuki SM; Cole TB; Park SS; Richter RJ; Furlong CE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12780-4. PubMed ID: 18711144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environmental interactions and organophosphate toxicity.
    Povey AC
    Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.